Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Interactive Cardiovascular and Thoracic Surgery
|
June 21, 2021
Lymph node dissection in thymic carcinomas and neuroendocrine carcinomas
Masatsugu Hamaji, Mitsugu Omasa, Takao Nakanishi, et al.
Iscience
|
August 7, 2024
A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinoma
Xue-Liang Fang, Lian-Zhen Zhong, Wei Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2024
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial
Cheng-Long Huang, Ning Zhang, Wei Jiang, et al.
Surgery Today
|
January 15, 2025
Clinical significance of the preoperative prognostic nutritional index in patients with resectable non-small cell lung cancer: a multicenter study
Mamoru Takahashi, Akihiro Aoyama, Masatsugu Hamaji, et al.
Surgery Today
|
August 11, 2020
The treatment and survival of patients with postoperative recurrent thymic carcinoma and neuroendocrine carcinoma: a multicenter retrospective study
Ryo Miyata, Masatsugu Hamaji, Mitsugu Omasa, et al.
Surgery Today
|
July 2, 2022
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis
Ryo Miyata, Masatsugu Hamaji, Akiyoshi Nakakura, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 23, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study
Ryo Miyata, Masatsugu Hamaji, Atsushi Kawaguchi, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
Ling-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
The Lancet. Oncology
|
September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology
|
September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Interactive Cardiovascular and Thoracic Surgery
|
June 21, 2021
Lymph node dissection in thymic carcinomas and neuroendocrine carcinomas
Masatsugu Hamaji, Mitsugu Omasa, Takao Nakanishi, et al.
Iscience
|
August 7, 2024
A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinoma
Xue-Liang Fang, Lian-Zhen Zhong, Wei Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2024
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial
Cheng-Long Huang, Ning Zhang, Wei Jiang, et al.
Surgery Today
|
January 15, 2025
Clinical significance of the preoperative prognostic nutritional index in patients with resectable non-small cell lung cancer: a multicenter study
Mamoru Takahashi, Akihiro Aoyama, Masatsugu Hamaji, et al.
Surgery Today
|
August 11, 2020
The treatment and survival of patients with postoperative recurrent thymic carcinoma and neuroendocrine carcinoma: a multicenter retrospective study
Ryo Miyata, Masatsugu Hamaji, Mitsugu Omasa, et al.
Surgery Today
|
July 2, 2022
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis
Ryo Miyata, Masatsugu Hamaji, Akiyoshi Nakakura, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 23, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study
Ryo Miyata, Masatsugu Hamaji, Atsushi Kawaguchi, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
Ling-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
The Lancet. Oncology
|
September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology
|
September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Page
of 16